Exclusive Summary

• Backed by US-FDA GMP and US market registration, offering the highest tier of quality endorsement to fast-track market access and distributor confidence globally.
• Listed as a WHO Essential Medicine, it addresses a massive, rigid global demand of tens of millions of patients across hemodialysis, cardiovascular surgeries, and VTE treatments.
• Positioned to resolve frequent global heparin supply shortages by leveraging China's vertical API integration, ensuring distributors highly competitive pricing and resilient supply chains.